𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of carboplatin as a single drug for relapsed Wilms' tumor: Experience of the Brazilian Wilms' tumor study group

✍ Scribed by De Camargo, Beatriz ;Melaragno, Renato ;Silva, Nagsla Saba E ;Mendoncla, Nubia ;Alvares, Maria Nunes ;Morinaka, Elizabeth ;Marques, Armando ;Cusato, Maria P.

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
256 KB
Volume
22
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A total of 15 patients with relapsed Wilms' tumor were treated with carboplatin as a single agent. There were six females and nine males, aged between 2 and 9 years (me‐dian:5). The treatment consisted of carboplatin given I.V. as a single agent at a dose of 550 mg/m^2^ over 1 hour every 3 weeks. There were four (26%) complete responses, four (26%) partial responses, one stable disease, and six with progressive disease. In all patients a total of 56 courses were given and the toxicities found were leukopenia and thrombocytopenia. The overall response rate was encouraging and the toxicity was acceptable and reversible. Β© 1994 Wiley‐Liss, Inc.

πŸ“œ SIMILAR VOLUMES

A randomized clinical trial of single-do
A randomized clinical trial of single-dose versus fractionated-dose dactinomycin in the treatment of wilms' tumor. Results after extended follow-up
✍ Beatriz De Camargo; Eduardo L. Franco; Brazilian Wilms' Tumor Study Group πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 500 KB

for the Brazilian Wilms' Tumor Study Group$ Background. To verify the adequacy of a simplified chemotherapeutic regimen for the treatment of Wilms' tumor (WT), the authors conducted a clinical trial to compare the standard fractionated dose (15 mcg/kg x 5 days) of dactinomycin (AMD) with a single do

Teniposide (VM-26) as a single drug trea
Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma : A Phase II study of the Southwest Oncology Group
✍ Petre N. Grozea; John J. Crowley; Vikki A. Canfield; Laura Kingsbury; S. William πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 3 views

## Background: Teniposide (vm-26) was reported to have activity in small cell lung carcinoma (sclc). the authors performed a phase ii study of teniposide as a treatment for patients with previously untreated extensive sclc. ## Methods: The study was open to patients with a histologic or cytologic